JAMUNARANI VEERARAGHAVAN to Tamoxifen
This is a "connection" page, showing publications JAMUNARANI VEERARAGHAVAN has written about Tamoxifen.
Connection Strength
0.064
-
Therapeutic role of recurrent ESR1-CCDC170 gene fusions in breast cancer endocrine resistance. Breast Cancer Res. 2020 08 08; 22(1):84.
Score: 0.034
-
The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance. Br J Cancer. 2019 02; 120(3):331-339.
Score: 0.030